Pulmonx (LUNG) Operating Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Operating Expenses data on file, last reported at $30.4 million in Q3 2025.

• On a quarterly basis, Operating Expenses rose 4.42% year-over-year to $30.4 million in Q3 2025; TTM through Dec 2025 was $93.4 million, a 22.01% decrease from a year earlier, with the FY2024 full-year figure at $119.7 million, up 6.23% from the prior year.
• Operating Expenses for Q3 2025 stood at $30.4 million, down from $32.0 million in the prior quarter.
• Over the last five years, Operating Expenses for LUNG reached as high as $32.0 million in Q2 2025 and fell as low as $19.1 million in Q1 2021.
• Historically, Operating Expenses has averaged $26.7 million across 5 years, with a median of $28.2 million in 2023.
• Across the five-year window, Operating Expenses jumped 73.16% in 2021 and grew 3.37% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $22.6 million in 2021, then climbed by 14.12% to $25.8 million in 2022, then rose by 9.72% to $28.3 million in 2023, then grew by 9.49% to $31.0 million in 2024, then decreased by 1.81% to $30.4 million in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were $30.4 million in Q3 2025, $32.0 million in Q2 2025, and $30.9 million in Q1 2025.